Nature Medicine

Papers
(The TQCC of Nature Medicine is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Questionable role of new techniques in IVF embryo culture2179
A genetic test to predict adverse drug reactions1798
LLMs get a medical education1588
Liquid biopsies and tumor mutational burden: the cutoff conundrum845
In vivo gene editing for inherited vision loss761
Recapitulating sensory feedback in artificial skin748
Telemonitoring for complicated pregnancies718
Rise in ambient temperature is associated with increased mortality in Latin America692
SCOTUS v. reproductive health in United States623
Easing the pain of endometriosis623
Longitudinal analysis shows how microbiome changes might influence responses to immune checkpoint blockade610
Author Correction: Financial incentives for COVID-19 vaccines in a rural low-resource setting: a cluster-randomized trial605
Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial587
Can an implanted minipump deliver for diabetes patients?549
Author Correction: Single-cell guided prenatal derivation of primary fetal epithelial organoids from human amniotic and tracheal fluids547
Not all KRAS-mutated pancreatic cancers are equal — mutant dosage matters540
The inconvenient reality of AI-assisted embryo selection in IVF534
Author Correction: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology504
Combating vaccine revisionism499
A global metric of immune health487
HIV prevention through PrEP in cisgender women486
An AI chatbot for talking therapy referrals478
Effects of vutrisiran on cardiac structure and function in patients with transthyretin amyloidosis with cardiomyopathy: secondary outcomes of the HELIOS-B trial475
Targeting the angiopoietin-like protein 3/8 complex with a monoclonal antibody in patients with mixed hyperlipidemia: a phase 1 trial444
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease432
Integrating the environmental and genetic architectures of aging and mortality429
The WHO genomics program of work for equitable implementation of human genomics for global health423
Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial417
Heterogeneous aging across multiple organ systems and prediction of chronic disease and mortality400
In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial398
An explainable foundation model for drug repurposing395
Changing climate and socioeconomic factors contribute to global antimicrobial resistance390
Continuous glucose monitoring and intrapersonal variability in fasting glucose389
First tumor-agnostic approval for an ADC389
Education of healthcare professionals to improve guideline adherence in atrial fibrillation: the STEEER-AF cluster-randomized clinical trial381
The effect of geopolitical flux on antimicrobial resistance379
Publisher Correction: GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial375
Ending the taboo on periods and period problems374
Pregnant and lactating women should be included in clinical trials for cardiovascular disease373
A fluid biomarker accurately detects tau aggregate pathology in Alzheimer’s disease371
Remotely delivered weight management for people with long COVID and overweight: the randomized wait-list-controlled ReDIRECT trial370
How virtual reality therapy is shaping mental health368
Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial367
Estimating the total effect of anthropogenic climate change on human health and wellbeing365
Concerns about the Burden of Proof studies363
PD-L1 and the dawn of modern cancer immunotherapy358
Promoting gender equity in the scientific and health workforce is essential to improve women’s health356
Supported decision-making can advance clinical research participation for people with disabilities349
Gene-edited pig liver successfully transplanted into human346
Author Correction: Digital consults in heart failure care: a randomized controlled trial345
FDA approves first drug to delay type 1 diabetes341
Author Correction: Unexplained post-acute infection syndromes340
Pembrolizumab for advanced urothelial carcinoma: exploratory ctDNA biomarker analyses of the KEYNOTE-361 phase 3 trial337
In utero origin of myelofibrosis presenting in adult monozygotic twins335
AI as a new paradigm for risk-based screening for breast cancer333
Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial332
The capacity of brain circuits to enhance psychiatry327
The role of research in China’s successful elimination of malaria326
Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma324
Publisher Correction: Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes321
HIPAA is a misunderstood and inadequate tool for protecting medical data319
Targeted therapy for osteoarthritis: progress and pitfalls314
Solving medicine’s data bottleneck: Nightingale Open Science310
Urgent action is needed to confront artemisinin partial resistance in African malaria parasites310
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial310
CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs304
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy302
The uncertain science of preimplantation and prenatal genetic testing298
Licensed H5N1 vaccines generate cross-neutralizing antibodies against highly pathogenic H5N1 clade 2.3.4.4b influenza virus296
A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer’s disease293
Will ChatGPT transform healthcare?293
Low-voltage-area ablation for persistent atrial fibrillation: a randomized controlled trial289
Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19286
Integrated image-based deep learning and language models for primary diabetes care283
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial283
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial280
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial277
The landscape of mRNA nanomedicine277
Hippocampal network activity forecasts epileptic seizures276
Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants276
Estimating future heat-related and cold-related mortality under climate change, demographic and adaptation scenarios in 854 European cities274
Health in the Amazon273
Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses273
Rethinking aspirin for heart health271
An outdated loophole is letting faulty lab tests hit the market270
An anti-obesity drug from the diabetes toolbox269
WHO sets research agenda for refugee and migrant health265
The Yearbook261
Mapping the cellular landscape of the brain259
How patient advocates influence health policy258
Menstrual health without stigma257
Using genetics to predict toxicity of cancer immunotherapy257
Brain pathology of COVID-19257
The effect of embryonic genome imbalances on pregnancy257
Air pollution interventions for health253
Microbes convert plastic waste into paracetamol253
An international treaty to regulate misuse of alcohol and cannabis253
From neoadjuvant to organ-sparing immunotherapy for colorectal cancer250
Maternal diabetes and risk of attention-deficit/hyperactivity disorder in offspring in a multinational cohort of 3.6 million mother–child pairs247
Publisher Correction: Integrating liver endpoints in clinical trials of cardiovascular and kidney disease247
Reply to Guyton, J. R. & Boden, W. E.; Schreiber, S. et al.242
Open Letter to G7 and G20 leaders: resolve global crises to secure our future240
Immune reconstitution inflammatory syndrome drives emergence of HIV drug resistance from multiple anatomic compartments in a person living with HIV239
Health benefits of calorie restriction237
A gene-by-sex interaction contributes to liver disease susceptibility in women237
An African One Health network for antimicrobial resistance and neglected tropical diseases236
Anti-amyloid could help prevent genetic form of Alzheimer’s disease235
Steps to prevent and respond to an H5N1 epidemic in the USA234
Acquired blood mutations cause acute kidney injury via dysregulated inflammation233
The visible and hidden mortality caused by flooding233
Oral obeldesivir provides postexposure protection against Marburg virus in nonhuman primates230
siRNA therapy lowers triglycerides in patients with rare condition230
Prenatal exposure to famine affects lifelong health227
Machine learning improves prediction of clinical outcomes for invasive breast cancers225
Coproducing health research with Indigenous peoples223
Meningioma risk stratification with a targeted gene-expression biomarker223
Using unlabeled data to enhance fairness of medical AI222
Mpox continues to spread in Africa and threatens global health security222
Multiomic analyses implicate a neurodevelopmental program in the pathogenesis of cerebral arachnoid cysts222
Author Correction: Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury221
Overcoming zero-sum thinking to advance US population health221
D3S-001 in advanced solid tumors with KRASG12C mutations: a phase 1 trial220
Geographical shifting of cholera burden in Africa and its implications for disease control219
A brief digital cognitive test improves Alzheimer’s disease detection217
Peace in Colombia requires healing the scars of conflict on the mind and brain216
The economics of investing in women and health214
Smartwatch- and smartphone-based remote assessment of brain health and detection of mild cognitive impairment214
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia211
Microbiome–metabolome dynamics associated with impaired glucose control and responses to lifestyle changes209
Advancing global antibiotic research, development and access208
Mutations in the U4 snRNA gene RNU4-2 cause one of the most prevalent monogenic neurodevelopmental disorders208
Multi-omic profiling a defined bacterial consortium for treatment of recurrent Clostridioides difficile infection207
Salt substitution and salt-supply restriction for lowering blood pressure in elderly care facilities: a cluster-randomized trial207
Large-scale genome-wide association study of coronary artery disease in genetically diverse populations207
Author Correction: Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial206
A digital health algorithm to guide antibiotic prescription in pediatric outpatient care: a cluster randomized controlled trial205
Clinical AI tools must convey predictive uncertainty for each individual patient204
Use of mobile diagnostics and digital clinical trials in cardiology204
Plasma proteome adaptations during feminizing gender-affirming hormone therapy203
Simulation-based estimates and projections of global, regional and country-level maternal mortality by cause, 1990–2050202
Technology-assisted cognitive-behavioral therapy for perinatal depression delivered by lived-experience peers: a cluster-randomized noninferiority trial199
Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial198
Strategies for shortening tuberculosis therapy198
Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials196
The airway microbiome mediates the interaction between environmental exposure and respiratory health in humans196
Prospective implementation of AI-assisted screen reading to improve early detection of breast cancer195
Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults195
Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial194
Familial confounding in the associations between maternal health and autism194
Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial193
A benchmarking crisis in biomedical machine learning193
Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis192
Emerging diagnostics and therapeutics for Alzheimer disease192
The limits of fair medical imaging AI in real-world generalization192
Personalized brain circuit scores identify clinically distinct biotypes in depression and anxiety192
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure192
AI-generated text may have a role in evidence-based medicine191
Self-improving generative foundation model for synthetic medical image generation and clinical applications191
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial191
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer187
Determinants of COVID-19 vaccination status and hesitancy among older adults in China185
Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity184
Genome-wide polygenic score to predict chronic kidney disease across ancestries183
Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial182
An integrated cell atlas of the lung in health and disease182
Gene therapy for alcohol-use disorder180
Could video games be good for your health?179
A human brain circuit for addiction remission177
A smart solution for detecting ear problems176
ALS therapy hits molecular mark but misses clinical one175
Pig-to-human transplants inch closer to reality174
A framework to assess the effects of genetic risk factors on disability-adjusted life years173
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial173
Human embryo models offer glimpse into early development173
Deciphering the heritability of human height172
A neural stem-cell treatment for progressive multiple sclerosis171
Permissive gun laws in the USA linked to thousands of child deaths167
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial167
Author Correction: Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants166
Hibernation science harnessed to treat obesity and modify metabolism166
Author Correction: The impact of school opening model on SARS-CoV-2 community incidence and mortality165
New neurons are born in the adult human brain164
Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma164
DASH4D diet for glycemic control and glucose variability in type 2 diabetes: a randomized crossover trial164
Escitalopram for agitation in Alzheimer’s dementia: a randomized controlled phase 3 trial163
Cities, communities and clinics can be testbeds for human exposome and aging research160
The VolREthics initiative to protect the well-being of healthy volunteers in biomedical research159
Hope for patients facing deadly infections159
Concern for the validity of short-term dietary crossover trials159
The economic value of reducing avoidable mortality159
Single-nucleus chromatin accessibility and transcriptomic map of breast tissues of women of diverse genetic ancestry158
Targeted radiation adds precision to cancer therapy158
Why paying individual people for their health data is a bad idea157
Using implementation science to navigate the complexity of integrating genomics into healthcare157
Retraction Note: EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers156
Gene-editing breakthrough for a rare hereditary disorder155
Imatinib and the dawn of precision cancer therapy154
Author Correction: T cell–encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection153
Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery153
Advancing clinical genomics with Middle Eastern and South Asian pangenomes152
Publisher Correction: Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial152
Adequate information about clinical trial results must be given to participants152
Teaching machines to doubt151
Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial150
Countering the impact of the climate crisis on health will require data147
Bacterial SNPs in the human gut microbiome associate with host BMI146
Determinants and inequities in healthy working life expectancy in China146
Liberal fluid intake versus fluid restriction in chronic heart failure: a randomized clinical trial146
The unseen climate health risks of antimicrobial resistance in urban informal settlements146
A federated learning system for precision oncology in Europe: DigiONE145
T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma145
CD40 ligand antagonist dazodalibep in Sjögren’s disease: a randomized, double-blinded, placebo-controlled, phase 2 trial144
An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolution144
Targeting KRAS in cancer142
AI-based selection of individuals for supplemental MRI in population-based breast cancer screening: the randomized ScreenTrustMRI trial142
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases141
First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial141
Differential peripheral immune signatures elicited by vegan versus ketogenic diets in humans139
Author Correction: Impact of the indigenous rotavirus vaccine Rotavac in the Universal Immunization Program in India during 2016–2020139
Africa’s continental plan to end cholera137
A H3K27M-targeted vaccine in adults with diffuse midline glioma137
Integrating liver endpoints in clinical trials of cardiovascular and kidney disease137
AI-guided precision parenteral nutrition for neonatal intensive care units136
Early detection of multiple cancer types using multidimensional cell-free DNA fragmentomics136
First-line serplulimab or placebo plus chemotherapy in PD-L1-positive esophageal squamous cell carcinoma: a randomized, double-blind phase 3 trial134
Pre-existing adaptive immunity to the RNA-editing enzyme Cas13d in humans134
Risk factors for PICU admission and death among children and young people hospitalized with COVID-19 and PIMS-TS in England during the first pandemic year134
Multi-ancestry polygenic mechanisms of type 2 diabetes133
Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma133
Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination133
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster132
Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine132
City-level impact of extreme temperatures and mortality in Latin America132
Mapping the mediators of Alzheimer’s disease131
Improving scientific integrity in Chinese medical institutions with the Hospital Research Integrity Alliance130
Modeling multiple myeloma heterogeneity in mice to advance therapeutic discoveries130
The role of placebo control in clinical trials for neurodegenerative diseases128
Boosting the efficacy of emergency contraception128
Blood lipid profiling indicates that dietary fat quality is associated with cardiometabolic risk128
Balancing the risks of HIV transmission at low viral load127
Author Correction: Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers126
Biological and health effects of fire smoke exposure126
‘Inverse vaccines’ could treat autoimmune disease — from multiple sclerosis to celiac disease126
Location matters for brain gene therapy in lysosomal disorders126
Education does not affect memory decline or brain aging126
Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial126
A joint international consensus statement for measuring quality of survival for patients with childhood cancer125
Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial125
The fragile intelligence of GPT-5 in medicine125
Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: exploratory biomarker analyses of a randomized phase 3 trial125
0.97747015953064